DellonES, LiacourasCA, Molina-InfanteJ, et al.Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. Gastroenterology. 2018; 155(4):1022–1033.e10.
2.
GuilletMH, WierzbickaE, GuilletS, et al.A 3-year causative study of pompholyx in 120 patients. Arch Dermatol. 2007; 143(12):1504–1508.
3.
Abreu-VelezAM, PintoFJJr, HowardMS. Dyshidrotic eczema: relevance to the immune response in situ. N Am J Med Sci. 2009; 1(3):117–120.
4.
WestonGK, HooperJ, StroberBE. Dupilumab in the treatment of dyshidrosis: a report of two cases. J Drugs Dermatol. 2018; 17(3):355–356.
5.
BlanchardC, StuckeEM, BurwinkelK, et al.Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. J Immunol. 2010; 184(7):4033–4041.
